Cargando…

Increased Risk of RSV Infection in Children with Down's Syndrome: Clinical Implementation of Prophylaxis in the European Union

Prospective cohort studies show that Down's syndrome (DS) is an independent risk factor for hospitalization for RSV bronchiolitis. It is unknown whether this observation has been translated into specific management for DS children. The primary goal was to assess the knowledge of healthcare prov...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Beek, Dianne, Paes, Bosco, Bont, Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708408/ https://www.ncbi.nlm.nih.gov/pubmed/23878586 http://dx.doi.org/10.1155/2013/801581

Ejemplares similares

Respiratory Syncytial Virus-related Death in Children With Down Syndrome: The RSV GOLD Study
por: Löwensteyn, Yvette N., et al.
Publicado: (2020)

The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with Down syndrome: A systematic review and meta–analysis
por: Chan, Markus, et al.
Publicado: (2017)

Burden of Respiratory Syncytial Virus in the European Union: estimation of RSV-associated hospitalizations in children under 5 years
por: Del Riccio, Marco, et al.
Publicado: (2023)

Using doxycycline for prophylaxis of bacterial sexually transmitted infections: considerations for the European Union and European Economic Area
por: Mårdh, Otilia, et al.
Publicado: (2023)

Compliance with RSV prophylaxis: Global physicians’ perspectives
por: Anderson, Kari S, et al.
Publicado: (2009)

A Multimodal Imaging-Supported Down Syndrome Mouse Model of RSV Infection
por: Tielemans, Birger, et al.
Publicado: (2023)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
por: Nederend, Maaike, et al.
Publicado: (2020)

Respiratory syncytial virus (RSV) disease – new data needed to guide future policy
por: Campbell, Harry, et al.
Publicado: (2015)

Quantifying the RSV immunity debt following COVID-19: a public health matter
por: Billard, Marie-Noëlle, et al.
Publicado: (2022)

Anti-RSV prophylaxis efficacy for infants and young children with cystic fibrosis in Ireland
por: Linnane, Barry, et al.
Publicado: (2015)

A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
por: Paes, B., et al.
Publicado: (2012)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
por: Gastaldi, Andrea, et al.
Publicado: (2021)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
por: Löwensteyn, Yvette N., et al.
Publicado: (2021)

Correction to: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
por: Löwensteyn, Yvette N., et al.
Publicado: (2021)

The Burden of Norovirus Disease in Children in the European Union
por: Kowalzik, Frank, et al.
Publicado: (2015)

Does RSV prophylaxis prevents future recurrent wheeze in preterm infants?
por: Ignacio, Lena, et al.
Publicado: (2013)

Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
por: Bollani, Lina, et al.
Publicado: (2015)

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2023)

The European Health Union and the protection of public health in the European Union: Is the European Union prepared for future cross-border health threats?
por: Seitz, Claudia
Publicado: (2023)

EHMTI-0192. Onabotulinumtoxina prophylaxis in chronic migraine utilization and patient characteristics: observational study in the European Union
por: Matharu, M, et al.
Publicado: (2014)

The European Union and the Regions /
Publicado: (1995)

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children
por: Simões, Eric A. F., et al.
Publicado: (2018)

RSV: perspectives to strengthen the need for protection in all infants
por: Navarro Alonso, Jose Antonio, et al.
Publicado: (2021)

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries
por: Bont, Louis, et al.
Publicado: (2016)

Incorporating data from multiple endpoints in the analysis of clinical trials: example from RSV vaccines
por: Prunas, Ottavia, et al.
Publicado: (2023)

Prophylaxis protects infants with congenital heart disease from severe forms of RSV infection: an Italian observational retrospective study: Palivizumab prophylaxis in children with congenital heart disease
por: Ratti, Chiara, et al.
Publicado: (2023)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)

Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases
por: Manzoni, Paolo, et al.
Publicado: (2017)

Nosocomial RSV-related In-hospital Mortality in Children <5 Years: A Global Case Series
por: Löwensteyn, Yvette N., et al.
Publicado: (2022)

European Union implementation of Article 5.3 of the Framework Convention on Tobacco Control
por: Hawkins, Benjamin, et al.
Publicado: (2018)

The assessment of future RSV immunizations: How to protect all infants?
por: Bont, Louis, et al.
Publicado: (2022)

A systematic review on global RSV genetic data: Identification of knowledge gaps
por: Langedijk, Annefleur C., et al.
Publicado: (2021)

Epidemiology of human West Nile virus infections in the European Union and European Union enlargement countries, 2010 to 2018
por: Young, Johanna J, et al.
Publicado: (2021)

Specificity and Effector Functions of Human RSV-Specific IgG from Bovine Milk
por: den Hartog, Gerco, et al.
Publicado: (2014)

Local IL-17A Potentiates Early Neutrophil Recruitment to the Respiratory Tract during Severe RSV Infection
por: Stoppelenburg, Arie Jan, et al.
Publicado: (2013)

Burnout syndrome as an occupational disease in the European Union: an exploratory study
por: LASTOVKOVA, Andrea, et al.
Publicado: (2017)

Report on the state of the European Union /
Publicado: (2005)

The government and politics of the European Union /
por: Nugent, Neill
Publicado: (1994)

Bluetongue Epidemiology in the European Union
por: Saegerman, Claude, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_a1qb7qd5nmomhi2g8j2leh3g2l